Mouse Models of Pancreatic Ductal Adenocarcinoma
- PMID: 26226900
- DOI: 10.1016/j.hoc.2015.04.010
Mouse Models of Pancreatic Ductal Adenocarcinoma
Abstract
Only 10% to 15% of patients with pancreatic ductal adenocarcinoma (PDAC) are candidates for potentially curative surgery due to the location or spread of disease at the time of diagnosis. Despite rapid progress in the understanding of the molecular mechanisms underlying PDAC, translation to effective therapies has been modest at best. One of the key tools available for studying biology and developing more effective therapeutics is the laboratory mouse, mus musculus. This article explores new and innovative approaches to mouse modeling and how these approaches can be utilized to move the field forward.
Keywords: Genetic engineered mouse models; Kras; Models of cancer; Pancreatic cancer; Therapeutics.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.J Pathol. 2014 Oct;234(2):228-38. doi: 10.1002/path.4402. Epub 2014 Aug 4. J Pathol. 2014. PMID: 25042889
-
Critical role of oncogenic KRAS in pancreatic cancer (Review).Mol Med Rep. 2016 Jun;13(6):4943-9. doi: 10.3892/mmr.2016.5196. Epub 2016 Apr 27. Mol Med Rep. 2016. PMID: 27121414 Review.
-
Therapeutic effects of an anti-Myc drug on mouse pancreatic cancer.J Natl Cancer Inst. 2014 Oct 11;106(12):dju320. doi: 10.1093/jnci/dju320. Print 2014 Dec. J Natl Cancer Inst. 2014. PMID: 25306215
-
Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport.Mol Cell. 2017 Aug 17;67(4):685-701.e6. doi: 10.1016/j.molcel.2017.07.014. Epub 2017 Aug 10. Mol Cell. 2017. PMID: 28803777 Free PMC article.
-
KRAS-related proteins in pancreatic cancer.Pharmacol Ther. 2016 Dec;168:29-42. doi: 10.1016/j.pharmthera.2016.09.003. Epub 2016 Sep 3. Pharmacol Ther. 2016. PMID: 27595930 Review.
Cited by
-
The Expression of Two Distinct Sets of Glycolytic Enzymes Reveals Differential Effects of Glycolytic Reprogramming on Pancreatic Ductal Tumorigenesis in Mice.Biomedicines. 2023 Nov 2;11(11):2962. doi: 10.3390/biomedicines11112962. Biomedicines. 2023. PMID: 38001963 Free PMC article.
-
Pancreatic cancer: Current status and Challenges.Curr Pharmacol Rep. 2017 Dec;3(6):396-408. doi: 10.1007/s40495-017-0112-3. Epub 2017 Oct 11. Curr Pharmacol Rep. 2017. PMID: 29404265 Free PMC article.
-
Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis.Mol Ther. 2018 Apr 4;26(4):1020-1031. doi: 10.1016/j.ymthe.2018.02.018. Epub 2018 Feb 23. Mol Ther. 2018. PMID: 29550075 Free PMC article.
-
Therapeutic Strategies Targeting Tumor Suppressor Genes in Pancreatic Cancer.Cancers (Basel). 2021 Aug 3;13(15):3920. doi: 10.3390/cancers13153920. Cancers (Basel). 2021. PMID: 34359820 Free PMC article. Review.
-
A timeline of tumour-associated macrophage biology.Nat Rev Cancer. 2023 Apr;23(4):238-257. doi: 10.1038/s41568-022-00547-1. Epub 2023 Feb 15. Nat Rev Cancer. 2023. PMID: 36792751 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous